The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under Medicare and Medicaid, which has disappointed some healthcare leaders.

HHS underwent a sweeping restructuring this week, resulting in about 10,000 layoffs across various agencies. With critical ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

The Trump administration recently cancelled billions of dollars in funding to the NIH. Healthcare experts say the funding ...

The Supreme Court will soon hear oral arguments for a case that threatens coverage of preventive services without cost-sharing. Experts say this could make it significantly harder for patients to ...

About 90% of healthcare organizations are insecurely connected to the internet and running systems vulnerable to exploitation ...

All healthcare entities storing or transferring patient health information needs to be aware of a proposed update to HIPAA ...

Health tech companies made several major funding announcements in March. Here is a list of some of the biggest funding rounds.

Benefits leaders at the nation’s largest employers are managing massive healthcare cost increases, and that’s driving change in how they design their health benefits offerings. I’ve talked ...

Over the past couple years, tech experts and hospital leaders alike have been signing the praises of AI scribes. These tools — which ambiently listen to patient-provider interactions and provide ...